TY - CHAP
T1 - Immunological landscape of solid cancer
T2 - Interplay between tumor and autoimmunity
AU - Singh, Ajay K.
AU - Duddempudi, Phaneendra K.
AU - Kenchappa, Divya Borasandra
AU - Srivastava, Nityanand
AU - Amdare, Nitin P.
N1 - Publisher Copyright:
© 2024
PY - 2024/1
Y1 - 2024/1
N2 - The immune system, a central player in maintaining homeostasis, emerges as a pivotal factor in the pathogenesis and progression of two seemingly disparate yet interconnected categories of diseases: autoimmunity and cancer. This chapter delves into the intricate and multifaceted role of the immune system, particularly T cells, in orchestrating responses that govern the delicate balance between immune surveillance and self-tolerance. T cells, pivotal immune system components, play a central role in both diseases. In autoimmunity, aberrant T cell activation drives damaging immune responses against normal tissues, while in cancer, T cells exhibit suppressed responses, allowing the growth of malignant tumors. Immune checkpoint receptors, example, initially explored in autoimmunity, now revolutionize cancer treatment via immune checkpoint blockade (ICB). Though effective in various tumors, ICB poses risks of immune-related adverse events (irAEs) akin to autoimmunity. This chapter underscores the importance of understanding tumor-associated antigens and their role in autoimmunity, immune checkpoint regulation, and their implications for both diseases. It also explores autoimmunity resulting from cancer immunotherapy and shared molecular pathways in solid tumors and autoimmune diseases, highlighting their interconnectedness at the molecular level. Additionally, it sheds light on common pathways and epigenetic features shared by autoimmunity and cancer, and the potential of repurposing drugs for therapeutic interventions. Delving deeper into these insights could unlock therapeutic strategies for both autoimmunity and cancer.
AB - The immune system, a central player in maintaining homeostasis, emerges as a pivotal factor in the pathogenesis and progression of two seemingly disparate yet interconnected categories of diseases: autoimmunity and cancer. This chapter delves into the intricate and multifaceted role of the immune system, particularly T cells, in orchestrating responses that govern the delicate balance between immune surveillance and self-tolerance. T cells, pivotal immune system components, play a central role in both diseases. In autoimmunity, aberrant T cell activation drives damaging immune responses against normal tissues, while in cancer, T cells exhibit suppressed responses, allowing the growth of malignant tumors. Immune checkpoint receptors, example, initially explored in autoimmunity, now revolutionize cancer treatment via immune checkpoint blockade (ICB). Though effective in various tumors, ICB poses risks of immune-related adverse events (irAEs) akin to autoimmunity. This chapter underscores the importance of understanding tumor-associated antigens and their role in autoimmunity, immune checkpoint regulation, and their implications for both diseases. It also explores autoimmunity resulting from cancer immunotherapy and shared molecular pathways in solid tumors and autoimmune diseases, highlighting their interconnectedness at the molecular level. Additionally, it sheds light on common pathways and epigenetic features shared by autoimmunity and cancer, and the potential of repurposing drugs for therapeutic interventions. Delving deeper into these insights could unlock therapeutic strategies for both autoimmunity and cancer.
KW - Autoimmunity
KW - Immunity
KW - Inflammation
KW - Solid cancer
KW - Tumor microenvironment
UR - http://www.scopus.com/inward/record.url?scp=85194940935&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85194940935&partnerID=8YFLogxK
U2 - 10.1016/bs.ircmb.2024.04.002
DO - 10.1016/bs.ircmb.2024.04.002
M3 - Chapter
AN - SCOPUS:85194940935
SN - 9780443235504
T3 - International Review of Cell and Molecular Biology
SP - 163
EP - 235
BT - Targeting Signaling Pathways in Solid Tumors - Part C
A2 - Mukherjee, Sumit
A2 - Chatterjee, Kaushiki
PB - Elsevier Inc.
ER -